Jefferies assumes Sequenom (SQNM +0.7%) at Buy (price target $6) citing momentum for the...


Jefferies assumes Sequenom (SQNM +0.7%) at Buy (price target $6) citing momentum for the company's MaterniT21 test which analyst Brandon Couillard says is "ramp[ing] at a blistering clip." (Related: Credit Suisse sees robust test volumes)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs